We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

100 hedge funds and large institutions have $192M invested in Adverum Biotechnologies in 2018 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,604% more call options, than puts

Call options by funds: $3.19M | Put options by funds: $187K

67% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 21

21% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 24

4% more funds holding

Funds holding: 96 → 100 (+4)

0.32% more ownership

Funds ownership: 5.57% → 5.89% (+0.32%)

4% less capital invested

Capital invested by funds: $201M → $192M (-$8.83M)

Holders
100
Holders Change
+4
Holders Change %
+4.17%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
35
Reduced
21
Closed
24
Calls
$3.19M
Puts
$187K
Net Calls
+$3M
Net Calls Change
-$225K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$15.7M
2
State Street
State Street
Massachusetts
+$4.97M
3
Citadel Advisors
Citadel Advisors
Florida
+$4.06M
4
JP Morgan Chase
JP Morgan Chase
New York
+$3.34M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.01M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$9.1M
2
Goldman Sachs
Goldman Sachs
New York
-$3.68M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.21M
4
NC
Nexthera Capital
New York
-$2.91M
5
HCM
Highbridge Capital Management
New York
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
51
Principal Financial Group
Iowa
$214K +$243K +4,036 New
DS
52
DRW Securities
Illinois
$212K +$90.2K +1,500 +60%
Invesco
53
Invesco
Georgia
$207K -$204K -3,392 -46%
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$192K – – –
AIG
55
American International Group
New York
$188K +$213K +3,547 New
AQR Capital Management
56
AQR Capital Management
Connecticut
$184K +$209K +3,477 New
BIM
57
Bogle Investment Management
Massachusetts
$154K -$16.1K -268 -8%
MIM
58
MetLife Investment Management
New Jersey
$150K +$170K +2,834 New
SM
59
Sabby Management
Florida
$144K -$1.03M -17,170 -86%
BFM
60
Boothbay Fund Management
New York
$126K -$657K -10,931 -82%
BNP Paribas Financial Markets
61
BNP Paribas Financial Markets
France
$126K +$142K +2,369 +236,900%
Creative Planning
62
Creative Planning
Kansas
$121K +$59.8K +994 +77%
RG
63
Redmile Group
California
$118K – – –
Barclays
64
Barclays
United Kingdom
$117K -$443K -7,372 -77%
Russell Investments Group
65
Russell Investments Group
United Kingdom
$110K -$12K -200 -9%
VOYA Investment Management
66
VOYA Investment Management
Georgia
$107K +$122K +2,021 New
MLICM
67
Metropolitan Life Insurance Company (MetLife)
New York
$106K +$120K +2,002 New
JMPWA
68
JP Morgan Private Wealth Advisors
California
$106K – – –
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$84K +$95.5K +1,588 New
Brown Advisory
70
Brown Advisory
Maryland
$83K -$1.98K -33 -2%
AIM
71
Assured Investment Management
New York
$83K +$94.5K +1,571 New
CS
72
Credit Suisse
Switzerland
$82K +$93.6K +1,557 New
FRM
73
Fox Run Management
Connecticut
$80K +$25.1K +418 +38%
UBS Group
74
UBS Group
Switzerland
$74K +$68.6K +1,140 +444%
CSS
75
Cubist Systematic Strategies
Connecticut
$72K -$191K -3,172 -70%
1 2
3
4 5

ADVM Hedge Fund Activity: Q2 2018 in Review

100 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q2 2018, worth a combined $192M — down 4.4% from $201M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ADVM positions and 24 closed out — a net gain of 5 holders — while 35 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $15.7M. The largest seller was Millennium Management, cutting an estimated $9.1M.

  • 100 institutional investors held Adverum Biotechnologies (ADVM) as of Q2 2018, up from 96 in Q1 2018.
  • Funds reported $192M of Adverum Biotechnologies stock for Q2 2018, down 4.4% quarter-over-quarter.
  • 29 funds opened new Adverum Biotechnologies positions in Q2 2018 and 24 closed out, a net change of +5 holders.
  • The largest Adverum Biotechnologies buyer in Q2 2018 was BlackRock, an estimated $15.7M added.
  • The largest Adverum Biotechnologies seller in Q2 2018 was Millennium Management, an estimated $9.1M sold.

Based on aggregated 13F filings for Q2 2018.